Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitric oxide added to cardiopulmonary bypass in children with congenital heart disease
ACTRN12615001376538Phase 3Completed
- Sponsor
- The Royal Children's Hospital
- Start
- Jan 2014
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of nitric oxide in Cardiovascular Malformation (CVM) (2 arms), sponsored by The Royal Children's Hospital. Primary endpoint: Proportion of patients with low cardiac output syndrome. Started Jan 2014; status: completed.
02
Drugs
nitric oxide
03
Conditions
Cardiovascular Malformation (CVM)
Beyond the preview
Go deeper on ACTRN12615001376538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615001376538.